mRNACT

WIPO WIPO 2021

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke mRNACT wurde als Wortmarke am 28.10.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 13. Juni 2023

Markenform Wortmarke
Aktenzeichen 1660204
Länder Australien Kanada Schweiz Island Liechtenstein Norwegen
Basismarke US Nr. 90720622, 19. Mai 2021
Anmeldedatum 28. Oktober 2021
Ablaufdatum 28. Oktober 2031

Markeninhaber

475 Green Oaks Parkway
Holly Springs NC 27540
US

Markenvertreter

151 West 42nd Street, 17th Floor New York NY 10036 US

Waren und Dienstleistungen

01 Medical, biological, and pharmaceutical preparations for scientific and research use, or for the manufacture of pharmaceuticals, namely, preparations containing messenger RNA for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research and medical research, namely, for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use
05 Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing messenger RNA for preventing and treating viruses and respiratory disorders; mRNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for pharmaceutical, medical or diagnostic purposes; drug carriers for medical use, namely, lipid nanoparticles for delivering drugs; lipid nanoparticles for drug delivery sold as an integral component of drugs; pharmaceutical preparations, namely, messenger RNA and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells; medical, biological, and pharmaceutical preparations for medical laboratory use, namely, preparations containing messenger RNA for preventing and treating viruses and respiratory disorders
42 Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
44 Medical services; medical information; providing medical information via a website
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
12. Juni 2023 2023/24 Gaz NO Ablehnung
12. Mai 2023 2023/20 Gaz LI Ablehnung
22. März 2023 2023/12 Gaz CH Ablehnung
20. Juli 2022 2022/29 Gaz AU Ablehnung
28. Oktober 2021 2022/17 Gaz US Eintragung

ID: 141660204